# Lignosus Rhinoceros TM02® as a Complementary Therapy for Uncontrolled Asthma

> **NCT06451328** · PHASE2 · COMPLETED · sponsor: **University of Malaya** · enrollment: 17 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Lignosus rhinoceros TM02®

## Key facts

- **NCT ID:** NCT06451328
- **Lead sponsor:** University of Malaya
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-01
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2024-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06451328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06451328, "Lignosus Rhinoceros TM02® as a Complementary Therapy for Uncontrolled Asthma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06451328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*